Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Cash flows from operating activities:    
Net loss $ (40,441) $ (41,306)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation 4,388 674
Amortization of right-of-use assets 407 388
Stock-based compensation 22,117 6,717
Changes in fair value of convertible preferred stock warrants and common stock warrants (44,040) (3,679)
Loss on early debt extinguishment 0 60
Changes in operating assets and liabilities:    
Accounts receivable (6) 0
Inventory (452) 0
Prepaid expenses and other assets (2,004) (1,645)
Deferred contract costs 3,015 (1,279)
Accounts payable (192) (357)
Accrued expenses and compensation (122) 3,173
Deferred revenue (3,527) 2,290
Other liabilities (46) 450
Net cash used in operating activities (60,903) (34,514)
Cash flows from investing activities:    
Purchase of property and equipment (31,366) (31,509)
Net cash used in investing activities (31,366) (31,509)
Cash flows from financing activities:    
Proceeds from Business Combination and PIPE financing 0 405,155
Payments of transaction costs related to Business Combination and PIPE financing 0 (29,641)
Proceeds from exercise of common stock warrants, net 52,828 0
Proceeds from secured promissory notes, converted promissory notes and paycheck protection program loan 0 15,000
Repayment of secured promissory note 0 (15,000)
Payment of debt issuance costs 0 (90)
Proceeds from exercise of convertible preferred stock warrants 0 102
Proceeds from the exercise of stock options 2,052 163
Proceeds from issuance of common stock under employee stock purchase plan 1,112 0
Repurchase of unvested restricted common stock (9) (13)
Net cash provided by financing activities 55,983 375,676
Change in cash, cash equivalents, and restricted cash (36,286) 309,653
Cash and cash equivalents and restricted cash, beginning of period 385,418 29,218
Cash and cash equivalents, and restricted cash, end of period 349,132 338,871
Supplemental cash flow data (Non-cash):    
Net liabilities assumed from Business Combination 0 73,400
Purchase of property and equipment included in liabilities 4,689 2,606
Accrued transaction costs $ 794 $ 1,370